The Patent Finder

Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins

Moderna Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,303,079Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
In force
 · High confidence
UsedRemaining
Moderna Therapeutics, Inc.In forceHigh confidence
US 9,572,897Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 10,463,751Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
US 11,564,998Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
In force
 · High confidence
ModernaTX, Inc.In forceHigh confidence
Application 18/161,598Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins
Pending
Not granted
ModernaTX, Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Moderna Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited